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Background: Cyclic AMP (cAMP) and cyclic GMP (cGMP) have roles in relaying external signals and modifying gene
expression within cells in all phyla. Currently there are no reporter systems suitable for bacteria and plant cells that
measure alterations in downstream gene expression following changes in intracellular levels of cyclic nucleotides.
As the plant protein OLIGOPEPTIDE TRANSPORTER X (OPTX) is upregulated by cGMP, we fused the OPTX promoter
to a luciferase reporter gene (OPTX:LUC) to develop a plant cell reporter of cGMP-induced gene expression. We
prepared a second construct augmented with three mammalian cGMP response elements (OPTXcGMPRE:LUC)
and a third construct containing five gibberellic acid response elements (OPTXGARE:LUC). All three constructs
were tested in bacteria and isolated plant protoplasts.
Results: Membrane permeable cGMP enhanced luciferase activity of OPTX:LUC and OPTXGARE:LUC in protoplasts.
Treatment with the plant hormone gibberellic acid which acts via cGMP also generated downstream luciferase activity.
However, membrane permeable cAMP induced similar responses to cGMP in protoplasts. Significantly increased
luciferase activity occurred in bacteria transformed with either OPTXcGMPRE:LUC or OPTXGARE:LUC in response to
membrane permeable cAMP and cGMP. Bacteria co-transformed with OPTXcGMPRE:LUC or OPTXGARE:LUC and the
soluble cytoplasmic domain of phytosulfokine receptor1 (PSKR1; a novel guanylate cyclase) had enhanced luciferase
activity following induction of PSKR1 expression.
Conclusions: We have developed promoter reporter systems based on the plant OPTX promoter that can be
employed in bacteria and isolated plant cells. We have shown that it can be used in bacteria to screen recombinant
proteins for guanylate cyclase activity as increases in intracellular cGMP levels result in altered gene transcription and
luciferase activity.
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Cyclic AMP (cAMP) and cyclic GMP (cGMP) are major
signaling molecules generated from ATP or GTP by the
action of adenylate cyclases or guanylate cyclases, respect-
ively. Cyclic AMP is found in all organisms where it regu-
lates enzyme activity and transcription factors although its
role(s) in plants is poorly documented possibly because
cAMP levels in plants are considerably lower than in
vertebrates and there is a lack of annotated adenylate
cyclases [1-3]. In mammalian cells cGMP is a transitory
molecule that directly regulates cyclic nucleotide gated
ion channels, protein kinases and activates specific* Correspondence: helen.irving@monash.edu
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reproduction in any medium, provided the orphosphodiesterases that degrade cGMP [4]. In mamma-
lian systems the physiological roles of cGMP are well
characterized in intestinal fluid and electrolyte homeosta-
sis, phototransduction, and vascular smooth muscle where
it mediates relaxation [4]. Guanylate cyclases and cGMP
are well represented in various invertebrates such as in-
sects, nematodes and echindermata; and the amoeba Dic-
tyostelium also uses cGMP as a chemo-attractant [5,6].
The role of cGMP in bacteria, fungi and plants has been
controversial [1,6-9]. However cGMP is now a relatively
well characterized second messenger in higher plants
(Figure 1) mediating a wide variety of physiological effects
ranging from plant hormone dependent responses to in-
duction of plant defense responses [7,9] and novel guany-
late cyclases have been partly characterized [10-15].
Although a guanylate cyclase from the cyanobacteria hasl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and







Figure 1 Schematic diagram showing the relationship between
cGMP, the plant hormone giberellic acid (GA), nitric oxide (NO)
and induction of gene expression in plant cells. Both GA and NO
can induce increases in cGMP levels which in turn stimulate specific
transcription factors (TFs) to induce gene transcription. The interaction
of cAMP with cGMP is less well understood in plants so the induction of
cAMP production is indicated by a question mark (?) and dashed lines.
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cyclase and cGMP system involved in bacterial encyst-
ment has been revealed in Rhodospirillum centenum and
by homology in other members of the α-proteabacteria
such as Rhizobium NGR234 [17]. Therefore cGMP ap-
pears to be a universal signaling molecule in eukaryotic
cells and to have roles in at least some prokaryotes.
Part of the controversy relating to cGMP being a second
messenger in non-animal cells is due to its transitory na-
ture and generally lower levels compared to cAMP. The
most reliable method to detect cGMP is by mass spec-
trometry [7,9] which is limited in its utility for time course
measurements essential for detecting molecules transi-
ently present in limited numbers of cells. Various antibody
based assays have been developed but these were tailored
for animal cells and the early assays detected spurious
components in non-animal cells [9]. Newer ELISA based
kits are more specific for cGMP but tend to under report
amounts of cGMP present in non-animal cells [13]. In
plant cells where there is a large vacuole, it is feasible that
local concentrations of cGMP are much higher than de-
tected with either mass spectrometry or antibody based
kits. To measure endogenous cGMP levels at a cellularlevel in real time in mammalian cells a fluorescent biosen-
sor FlincG was developed. FlincG contains the regulatory
domain of protein kinase G type I fused to the circular
permuted enhanced green fluorescent protein (GFP) and
has been used in transfected mammalian cells to detect
intracellular changes in cGMP over native dynamic ranges
[18]. Constructs of FlincG placed under the control of a
plant promoter have been expressed in plant cells and de-
tect endogenous changes in cGMP levels [19,20]. Alterna-
tive protein cGMP biosensors have been constructed
using cGMP binding domains in phosphodiesterases
(e.g. PDE5) and the blue fluorescent protein (mTagBFP)
that have been used in multiple parameter imaging with
FRET-based cAMP reporters in animal cells [21]. Pro-
moter reporter constructs containing the cAMP binding
protein response element have been extensively used in
mammalian systems to detect changes in cAMP that alter
gene expression [22-25]. Several luciferase based reporter
systems augmented with cAMP binding protein response
element are commercially available. Significant cross-talk
occurs between the cAMP and cGMP transcription regu-
latory pathways in mammalian cells [4] and hence these
reporter systems have also been used to detect changes in
gene expression via cGMP in mammalian cells [26,27].
The complexities of the interaction between the cyclic nu-
cleotide pathways has led to the development of a mam-
malian cGMP reporter system pathways using the cAMP
response element and overexpressed protein kinase G but
this system is unable to discriminate between cAMP and
cGMP [28]. Despite these advances in mammalian cells, a
reporter assay for plant cells that detects gene expression
induced by changes in intracellular levels of either cGMP
or cAMP levels is lacking.
Exogenous application of membrane permeable cGMP
in plant cells has been shown to alter the transcriptome
[29]. Maathuis [29] identified several genes that were up-
regulated in root cells following exposure to membrane
permeable cGMP. We selected three of these genes as be-
ing potentially suitable candidates to develop promoter:lu-
ciferase reporter constructs that result in the downstream
induction of gene expression in plant cells following intra-
cellular changes in cGMP levels. We show changes in ex-
pression of luciferase following treatment of plant cells
with membrane permeable cyclic nucleotides with one of
these constructs. Since this candidate promoter contained
a cGMP response element identified in mammalian cells
and another that was associated with gibberellic acid
(GA), we augmented the promoter with these response el-
ements and tested them in transiently transfected plant
cells. In addition, we tested the effectiveness of the candi-
date promoters on bacterial cells where we observed that
they reported changes in gene expression following treat-













Figure 2 Schematic diagrams of plasmids used and the
response elements incorporated. (A) cGMP responsive promoter
LUC plasmid used for transfection. (B) Mammalian cGMP response
element (cGMPRE) DNA sequence described in Hum et al. [22] top
and gibberellic acid (GA) response element (GARE) DNA sequence
described in Bastian et al. [35] bottom. (C) Schematic diagram of
plasmids used for transfection. SOS3 promoter; CHX21 promoter
showing the GARE present (green); OPTX promoter showing the
mammalian cGMPRE (orange, horizontal stripe) and GARE (green)
present, cGMPRE inserted and GARE inserted.
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Generation of cyclic nucleotide responsive promoter:
luciferase plasmid constructs
We selected three Arabidopsis thaliana genes previously
shown by Maathuis [29] to be induced by membrane per-
meable cGMP (8-bromoguanosine 3′,5′-cyclic monopho-
sphate sodium salt or 8-bromo cGMP) in root tissue.
SALT OVERLY SENSITIVE 3 (SOS3), CATION/H+ EX-
CHANGER 21 (CHX21) and OLIGOPEPTIDE TRANS-
PORTER X (OPTX) all showed at least a two fold increase
in expression that was verified by quantitative RT-PCR
[29]. The A. thaliana OPTX gene has been annotated as a
member of the plant oligopeptide transporter family
(although it was originally annotated as NTL1 (LOW
AFFINITY NITRATE TRANSPORTER)) and is predicted
to be a membrane bound transporter of small peptides.
Promoter fragments of approximately 1000 bp of SOS3,
CHX21 and OPTX were amplified and cloned into the plant
luciferase vector pLucTrap3(GW) [30] to create pSOS3:
LUC, pCHX21:LUC and pOPTX:LUC (Figure 2A and 2C).
We determined that SOS3, CHX21 and OPTX were
all expressed in freshly isolated leaf mesophyll proto-
plasts (Figure 3A) despite these genes being originally
identified in root tissue [29]. Analysis of Arabidopsis
microarray data through Genevestigator [31] also indi-
cates that these genes are all expressed in leaf tissue.
Hence the machinery (i.e. transcription factors and other
signaling molecules) that control their expression is
likely to be present in leaf tissue as well as roots. We
then tested the luciferase activity of each promoter
in freshly prepared Arabidopsis mesophyll protoplasts
treated with membrane permeable 8-bromo cGMP at
various concentrations (0, 0.1, 1, and 10 μM). Luciferase
activity was quantified and standardized by protein
content for each sample and results were expressed as
percentage of luciferase activity where the untreated
(no cGMP treatment) is equal to 100%. There was no
significant difference in luciferase activity for the SOS3
or CHX21 promoters at any cGMP concentration
(Figure 3B and 3C). However, the OPTX promoter
showed a significant increase in luciferase activity with
8-bromo cGMP treatments at 0.1 and 1 μM (Figure 3D).
The specificity of the promoter luciferase OPTX:LUC
construct was tested by treating protoplasts with a mem-
brane permeable form of cAMP, N6,2’-O-dibutyrylade-
nosine 3’:5’-cyclic monophosphate (or dibutyryl cAMP).
Dibutyryl cAMP and 8-bromo cGMP induced similar
levels of luciferase activity in protoplasts transiently
transfected with OPTX:LUC (Figure 4A) indicating that
both cyclic nucleotides can up-regulate expression of the
OPTX gene. Whether this is because response elements
in the promoter are not specific for cGMP in plants or
additional cAMP response elements are present remains
to be determined. It is possible that like mammaliancells [4] there is considerable cross talk between the ma-
chinery controlling gene expression in plant cells in re-
sponse to cyclic nucleotides. However, of the three
promoters examined in this study, only the OPTX pro-
moter contains both a mammalian cGMP and a putative
GA response element (Figure 2C).
Nitric oxide has been shown to lead to increases in
cytosolic cGMP levels in plants [32,33] as well as animal
systems [18,34]. To test whether the promoter luciferase
construct OPTX:LUC could be used to show physio-
logical differences in cGMP levels within plant proto-
plasts we used the nitric oxide donor DEA/NONOate at
30 nM which has been shown to induce increases in
cytosolic cGMP in plants [19]. The plant hormone gib-
berellic acid (GA) has also been shown to raise cGMP
levels in plants and induce gene expression at concentra-
tions such as 30 μM [19,20,35,36]. Therefore we used a
30 μM GA treatment as well in the transiently trans-
fected protoplast experiments. Protoplasts transfected
with OPTX:LUC showed a significant increase in lucifer-
ase activity when compared to the untreated control for



































































Figure 3 Effect of cGMP on the luciferase reporter constructs in plant protoplasts. (A) Detection of CHX21, SOS3 and OPTX transcripts in
Arabidopsis leaf mesophyll protoplasts. Control amplifications were also made of the UBQ10 gene from RNA samples with (+, plus) or without
(−, minus) reverse transcriptase (RT) for protoplasts (OPTX, SOS3 and CHX21) or leaf tissue (SOS3 and CHX21 only) and M refers to the lane containing
the DNA size ladder. (B-D) Arabidopsis leaf mesophyll protoplasts were transiently transfected with a promoter luciferase reporter construct (B: SOS3:
LUC (n = 4 – 5); C: CHX21:LUC (n = 3 – 4); D: OPTX:LUC (n = 3–6)) and treated with 0, 0.1, 1 or 10 μM 8-bromo cGMP. At least 3 biological replicates
were completed on different days for each promoter treatment combination. Luciferase was normalized against protein content and asterisks indicate
treatments significantly different from the control (P < 0.05; one way ANOVA, Dunnett’s multiple comparison post-test).
Wheeler et al. BMC Biotechnology 2013, 13:97 Page 4 of 10
http://www.biomedcentral.com/1472-6750/13/97Augmentation of the cyclic nucleotide sensitive
promoter OPTX
DNA sequence analysis of the three promoters showed
that only the OPTX promoter contained the mammalian
cGMP response element (AxAxxxxxTTCxAxAxT; -361 bp
upstream from ATG; Additional file 1) identified by
Hum et al. [22] (Figure 2B and 2C). To our knowledge
this cGMP response element is the only element respond-
ing to changes in intracellular cGMP that has been char-
acterized in animal cells or plant cells. To potentially
enhance cGMP sensitivity of the OPTX promoter we used
mutagenesis to incorporate an additional three mamma-
lian cGMP response elements to make OPTXcGMPRE:
LUC (Figure 2C). Arabidopsis protoplasts transfected with
the OPTXcGMPRE:LUC showed no significant difference
in luciferase activity for any of the cGMP concentrations
tested when compared to the untreated control (data not
shown). This could be because the mammalian response
element is ineffective in plants or alternatively it may be
due to the positioning of the augmented response ele-
ments close to the transcription start site where cGMPactivated DNA binding proteins may not correctly modu-
late the transcriptional machinery as the cGMP response
element is over 1000 bp upstream of NPR1/GCA in the
mammalian system [22,37].
A promoter analysis study identified a putative GA
response element (TAACAAA/G; Figure 2B) which is
found at a higher frequency in promoters of genes respon-
sive to GA [35]. Both the OPTX and CHX21 promoters
contained a GA response element sequence. The GA re-
sponse element is located −194 bp upstream from ATG in
the OPTX promoter (Additional file 1) and is found much
further from the start of the gene in CHX21 (−1023 bp
upstream from ATG; Additional file 1). Since GA induces
transient increases in cGMP that in turn directly alters ex-
pression of GA-induced genes in plants [36], we used mu-
tagenesis to incorporate five additional GA response
elements into the OPTX promoter to make OPTXGARE:
LUC (Figure 2C). Both the membrane permeable ana-
logues of cGMP and cAMP increased luciferase activity to
similar levels in protoplasts transfected with OPTXGARE:


























































Figure 4 Cyclic nucleotide induced luciferase activity in plant
protoplasts. Arabidopsis leaf mesophyll protoplasts were transiently
transfected with a promoter luciferase reporter construct and treated
as described below. At least 3 biological replicates were completed on
different days for each promoter treatment combination. (A) OPTX:LUC
treated with 0.1 or 1 μM 8-bromo cGMP or dibutyryl cAMP (n = 8–9);
(B) OPTX:LUC treated with 0.1 μM 8-bromo cGMP, 30 μM GA or 30 nM
DEA/NONOate (n = 6); (C) OPTXGARE:LUC treated with 0.1 μM 8-bromo
cGMP, 0.1 μM dibutyryl cAMP or 30 μM GA (n = 3). Luciferase was
normalized against protein content and asterisks indicate treatments
significantly different from the control (P < 0.05; one way ANOVA,
Dunnett’s multiple comparison post-test).
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portantly, GA treatment also significantly increased lucif-
erase activity (Figure 4C) supporting the premise that the
response element is likely to be activated downstream of
increases of cyclic nucleotides such as cGMP induced by
GA (Figure 1). These findings demonstrate that the OPTX
and OPTXGARE promoter reporter systems can be used
to report gene induction following increases in cyclic nu-
cleotide levels thereby reporting on a complete pathway
mediated through changes in cyclic nucleotide levels as
distinct from reporting specific changes in levels of the
cyclic nucleotides. When employed together with studies
using FlincG that reports on intracellular transient in-
creases of cGMP [19,20], the two systems will allow un-
raveling of conditions and levels of cyclic nucleotides
necessary to lead to changes in gene transcription.
OPTX promoters report cyclic nucleotide induced gene
activity in bacterial cells
To date, only members of the α-proteabacteria are known
to naturally synthesize cGMP although other bacteria pro-
duce cAMP and the di-cyclic nucleotides c-di-AMP and
c-di-GMP [1,17]. Therefore a system that detects cGMP
in bacteria would be particularly useful to screen for novel
and functional recombinant guanylate cyclases from other
organisms. One of our goals is to develop an assay that we
can use to detect novel recombinant guanylate cyclases
expressed in bacteria. With this concept in mind, we
tested the three OPTX constructs in the BL21-AI E. coli
strain which we selected as a representative bacterium
because it is suitable for high-level recombinant protein
expression. The OPTX:LUC, OPTXcGMPRE:LUC and
OPTXGARE:LUC were transformed separately into the
BL21-AI E. coli. At least four independently transformed
colonies were grown and tested for each promoter/ treat-
ment combination. We normalized each sample using
the OD600 reflecting cell number for the sample and
expressed the luciferase activity as a percentage of the
untreated control which was set at 100%. The promoter
OPTX:LUC showed no significant difference in luciferase
activity from the untreated control for 0.01 - 3 μM cGMP
treatments (data not shown). Conversely, expression of
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by cyclic nucleotide treatments. The OPTXcGMPRE:LUC
transformants showed a significant increase in luciferase
activity when treated with 0.3 μM, 1 μM and 3 μM
8-bromo cGMP but not 0.01 μM and 0.1 μM 8-bromo
cGMP (Figure 5A). However, this increase in luciferase
activity appears to be independent of the purine base as
similar changes were seen with treatments containing
dibutyryl cAMP (Figure 5B). The OPTXGARE:LUC showed
a significant increase in luciferase activity when com-
pared to the untreated control when 8-bromo cGMP
was between 0.1 μM and 0.3 μM but not at 0.01 μM or
1 μM (Figure 5C). Again similar increases were observed
in response to dibutyryl cAMP in BL21-AI cells trans-
formed with OPTXGARE:LUC (Figure 5D). To date no
known guanylate cyclases or cGMP signaling system has
been identified in E. coli although highly characterized
cAMP signal networks are present [1]. One possibility is
that the native bacterial transcription factors recognize
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Figure 5 Cyclic nucleotide induced luciferase activity in E. coli. BL21-A
treated with different concentrations of 8-bromo cGMP and dibutyryl cAMP. A
combination. (A) Effect of different concentrations of 8-bromo cGMP on B21A
dibutyryl cAMP on B21A-AI cells transformed with OPTXcGMPRE:LUC (n = 3–4
transformed with OPTX-GARE:LUC (n = 4). (D) Effect of dibutyryl cAMP on B21
expressed relative to OD600 to normalize results per cell number and asterisks
way ANOVA, Dunnett’s multiple comparison post-test).between them although it needs to be shown that E. coli
transcription factors can bind to response elements in
plant promoters.
The results shown in Figure 5 encouraged us to test if
we could detect cGMP in BL21-AI cells expressing a
novel guanylate cyclase. Previous work using BL21 cells
expressing the novel plant cytoplasmic guanylate cyclase
GC1 indicated that cGMP is generated within bacteria
during the period when protein expression is being
induced [12,15]. We have demonstrated that the cy-
toplasmic domain of the plant phytosulfokine receptor
(PSKR1) contains guanylate cyclase but not adenylate
cyclase activity [11] and chose this as the test protein.
We co-transformed bacteria with the cytoplasmic do-
main of PSKR1 and either OPTXcGMPRE or OPTX-
GARE to test if the expressed PSKR1 generates cGMP
that in turn induces downstream luciferase activity. At
3 hours following induction of PSKR1 expression, the lu-
ciferase activity is increased relative to the un-induced











































I cells transformed with a promoter luciferase reporter construct and
t least 3 separate colonies were tested for each promoter / treatment
-AI cells transformed with OPTXcGMPRE:LUC (n = 3–4); (B) Effect of
); (C) Effect of different concentrations of 8-bromo cGMP on B21A-AI cells
A-AI cells transformed with OPTXGARE:LUC (n = 6). Luciferase activity was
indicate treatments significantly different from the control (P < 0.05; one
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levels in the induced compared to the un-induced control
bacteria (Figure 6B) correlates with the induction of lucif-
erase activity. This is an exciting finding as it indicates that
these bacterial reporter assays can be used as a prelimin-
ary functional screen for novel guanylate cyclase enzymes.
The advantage of such a preliminary screen is that recom-
binant proteins containing guanylate cyclase activity are
identified prior to time consuming full characterization
studies as outlined in Figure 7.Conclusions
We have developed promoter reporter systems based on
the plant OPTX promoter that can be employed in bac-
teria and plant cells to report changes in gene expression
reflecting alterations in endogenous cyclic nucleotide
levels. The promoter is from the plant gene OPTX and
augmentation of the promoter reporter with cGMP and
GA response elements resulted in changes of efficacy in
the different cell types. In plant cells the OPTX and GARE
augmented reporter do not discriminate between cGMP
and cAMP but both respond to changes in intracellular
cGMP levels and both can be readily used in transiently
transfected protoplasts. Augmentation of the OPTX pro-
moter with either the GA or the separate cGMP response
elements allowed detection of increased levels of cyclic
nucleotides in bacteria. The augmented promoters can
also be employed to detect the activity of novel recombin-
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Figure 6 Detection of cGMP induced by the novel guanylate cyclase
specified promoter luciferase reporter construct (OPTXcGMPRE:LUC or OPTX
enzyme (pDESTPSKR1cd). Expression of PSKR1 was induced (+) in at least 4
relative to culture optical density to normalize results per cell number and rep
grown under the same conditions. (B) Relative amount of cGMP detected in
luciferase reporter constructs. Asterisks indicate treatments significantly differe
Tukey-Kramer multiple comparison post-test or B: student’s un-paired t-test).Methods
Plasmid construction
The promoter sequences for OLIGOPEPTIDE TRANS-
PORTER X (OPTX) [TAIR:AT1G33440; GenBank:NM_1
03069.3], SALT OVERLY SENSITIVE 3 (SOS3) [TAIR:
AT5G24270; GenBank:NM_122333] and CATION/H+ EX-
CHANGER 21 (CHX21) [TAIR:AT2G31910; GenBank:
NM_128749.2] were amplified from freshly prepared
Arabidopsis thaliana (Columbia-0) wild type genomic
DNA using primer pairs OPTX-P-fwd with OPTX -P-
rev, CHX21-P-fwd with CHX21-P-rev, and SOS3-P-fwd
with SOS3-P-rev, respectively (see Additional file 2: Table
S1 for primer sequences). These PCR products were used
as templates to incorporate gateway recombination
sites resulting in ~1000 bp promoter fragments with the
respective ATG start codon of each gene. The PCR
products were recombined separately into pDONR207
and confirmed by sequencing before recombination
into the pLUCTrap3 [GenBank:AY968054.1] [30] result-
ing in pOPTXLUC, pCHX21LUC and pSOS3LUC (see
Additional file 1 for full sequence). Sequencing confirmed
the LUCIFERASE encoding sequence was in frame with
the respective promoters. Three copies of the cGMP
Response Element (RE) [22] and five copies of the
Gibberellic Acid RE (GARE) [35] were incorporated
into the A. thaliana OPTX promoter using a Phusion
site-directed mutagenesis kit (Finnzymes, Thermo Scien-
tific, Scoresby VIC, Australia) following the manufacturer’s
instructions. The OPTX promoter in pDONR207 was
















PSKR1 in bacteria. (A) BL21-AI cells were co-transformed with the
GARE:LUC; n = 4) and a plasmid containing a novel guanylate cyclase
separate colonies and then luciferase activity was tested and expressed
orted relative to the non-induced control (−) co-transfected bacteria
non-induced (−) and induced (+) bacteria co-transfected with PSKR1 and
nt from control non-induced treatments (P < 0.05; A: one way ANOVA,
Select your cGMP inducing gene(s) of interest (such as a putative guanylate cyclase).
Clone the sequence of each of the genes you wish to assess into a protein expression vector
such as pDEST17TM (Invitrogen).
with either the OPTXcGMPR:LUC or
OPTXGARE:LUC reporter to assess if
cNMP is produced
Express the selected protein and verify in vitro
activity by assessing cGMP and or cAMP
produced using conventional kits or mass
spectrometry
(save time and money by only assessing the most
promising candidates)
Select most promising candidates to
investigate further
Mutagenesis of putative domains or residues
within the protein deemed important for cNMP
production
Figure 7 Flow chart showing a sample experimental plan. The flow of experiments show that by assessing the putative proteins of interest
using the OPTXcGMPRE:LUC or alternatively the OPTXGARE:LUC reporter the researcher can determine the ability of each recombinant protein to
induce cGMP or cAMP in vivo. The most promising candidates can be selected for further analysis as recombinant proteins using conventional
kits. Once the proteins are functionally verified, mutagenesis of putative functional domains or residues can be made then the researcher can
again utilize the OPTXcGMPRE:LUC or alternatively the OPTXGARE:LUC reporter system to determine the most promising candidates to pursue.
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Sequence was confirmed before the respective pro-
moter fragments were recombined into pLUCTrap3
to make pOPTXcGMPRELUC and pOPTXGARELUC
(see Additional file 1 for full sequences).
Plant growth, protoplast preparation and treatments
Arabidopsis thaliana (Col-0) leaves from 5 to 6 week
old plants were used to prepare protoplasts as previ-
ously described [38] and genomic DNA and total RNA
using Qiagen DNeasy and RNeasy plant kits (Qiagen,
Melbourne VIC, Australia) following the manufacturer’s
instructions except total RNA was treated with Ambion
DNase (Life Technologies, Melbourne VIC, Australia).
PureLink HiPure plasmid filter purification kit (Life Tech-
nologies) was used to purify transfection plasmid and for
each sample, 2 x 105 protoplasts were transfected with
100 μg p(promoter)LUCTRAP3(OPTX, CHX21, SOS3,
OPTXcGMPRE or OPTXGARE) and 900 ng of pUBQ10:
GUS as a comparative transfection control. Protoplasts
recovered in the dark at room temperature for 2 h before
treatment for 3 or 18 h with various concentrations of
8-bromo cGMP (Sigma, Castle Hill NSW, Australia),
N6,2’-O-dibutyryladenosine 3’:5’-cyclic monophosphate
(dibutyryl cAMP; Sigma), DEA/NONOate (Sigma) or
gibberellic acid (Sigma). Preliminary results indicated that
only low levels of luciferase were detected after 3 hour
treatments as we have previously observed [39] so 18 hourtreatments were used for the promoter analysis reported
here as this is a common time point used in luciferase re-
porter assays [40]. Following treatment each protoplast
sample was resuspended in 100 μl of 1X Reporter Lysis
Buffer (RBL, Promega, Sydney Australia) vortexed, centri-
fuged, then lysate was frozen in liquid nitrogen and stored
at −80°C. cDNA was generated using 100 ng of total RNA,
oligodT primer and SuperScript III Reverse Transcriptase
(Life Technologies). For each RNA template two identical
reactions either with (+) or without (−) SuperScript III
Reverse Transcriptase where included to ensure PCR prod-
ucts were amplified from the cDNA generated and not
contaminating genomic DNA. Volumes of 1 (UBQ10) to
4 μl (SOS3, CHX21, OPTX) from cDNA reactions were
used as template in PCR reactions and primers are
described in additional material (see Additional file 2:
Table S1).
Bacterial treatments
Competent BL21-AI cells (Life Technologies) were separ-
ately transformed with pLUCTRAP3(OPTX, OPTXcGMPRE
or OPTXGARE). At least four isolated colonies for each
plasmid were separately inoculated into 10 ml LB broth with
kanamycin (50 μg ml-1) and grown overnight. One ml of
overnight culture was used to inoculate 10 ml LB broth with
antibiotic selection and incubated at 37°C in a shaking incu-
bator to anOD600 of 0.5. Then 1 ml aliquots of each culture
were treated with specific concentrations of 8-bromo
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1.5 ml tubes. The OD600 of each culture was measured to
quantify the cell number using a UV/VIS spectrophotom-
eter (Spectum). After the 3 hour treatment, a 90 μl bacterial
sample was mixed with 10 μL of buffer (1 M K2HPO4 at
pH 7.8 and 20 mM EDTA) and the cultures were frozen on
dry ice. In some cases, BL21-AI cells were co-transformed
with either OPTXcGMPRE or OPTXGARE in pLUCTRAP3
(kanamycin resistance) and the cytoplasmic domain of
the phytosulfokine receptor 1 (PSKR1) [TAIR:AT2G02220;
GenBank:NP_1783300.1] in pDEST17 (pDEST17PSKR1cd;
ampicillin/carbenicillin resistance) [11]. Colonies were
selected with kanamycin (100 μg ml-1) and carbenicillin
(200 μg ml-1), separately inoculated into LB broth contain-
ing both antibiotics and grown to OD600 of about 0.5 when
the BL21-AI cells were induced with 0.2% L-arabinose and
1 mM IPTG to express the PSKR1 protein for 3 hours.
Triplicate technical replicates of at least three independent
co-transfected sample lysates were assessed using the
Amersham cGMP enzyme immunoassay Biotrak (EIA)
system following the standard (Protocol 3) as described
in the supplier’s manual (code RPN226, GE Healthcare,
Rydalmere NSW, Australia). The results were correlated
with cell number and expressed relative to the un-induced
sample as different colonies produced different amounts
of cGMP ranging from 30 to 200 fmol per sample.
Luciferase assay
Protoplasts and bacteria luciferase activity was assessed
using Promega’s Luciferase assay system (Promega, Sydney
NSW, Australia) following the manufacturer’s instruc-
tions. Luminescence of triplicate technical replicates on a
white 96 well plate was measured with the enhanced lumi-
nescence option using an EnVision 2101 plate reader
(PerkinElmer, Melbourne VIC, Australia). For bacteria,
luciferase activity was expressed relative to OD600 to
normalize results per cell number. For protoplasts, luciferase
was initially normalized against β-glucuronidase (GUS)
activity as described previously [39]. However comparison
of luciferase activity normalization using β-glucuronidase
versus protein revealed no significant difference as we have
previously observed [39] hence protoplast protein amount
was used for normalization in the data reported here.
Protein was assessed using a Nanodrop (Thermofisher
Scientific, Scoresby VIC, Australia).
Statistical analyses
Data was analyzed using one way analysis of variance
(ANOVA) followed by either Dunnett’s multiple compari-
son test (P < 0.05) or Tukey-Kramer multiple comparison
test (P < 0.05) using GraphPad Prism 6.0 (GraphPad
Software, La Jolla CA, USA). Where only two treatments
were compared, data was analyzed using the un-paired
student’s t-test. Data for each treatment contains at least 3biological replicates (n ≥ 3) and each experiment was
repeated at least twice.
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Additional file 2: Table S1. Primer sequences used in this study.
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